Loxiglumide, a CCK-A antagonist, in irritable bowel syndrome. A pilot multicenter clinical study

Ann N Y Acad Sci. 1994 Mar 23;713:449-50. doi: 10.1111/j.1749-6632.1994.tb44123.x.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study

MeSH terms

  • Administration, Oral
  • Colonic Diseases, Functional / drug therapy*
  • Colonic Diseases, Functional / physiopathology
  • Diarrhea / etiology
  • Diarrhea / prevention & control
  • Dose-Response Relationship, Drug
  • Pilot Projects
  • Proglumide / administration & dosage
  • Proglumide / analogs & derivatives*
  • Proglumide / therapeutic use
  • Receptors, Cholecystokinin / antagonists & inhibitors*

Substances

  • Receptors, Cholecystokinin
  • loxiglumide
  • Proglumide